Immunotherapy combination generates responses against castration-resistant metastatic prostate cancer

HOUSTON- Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at the American Society of Clinical Oncology Genitourinary Cancers Symposium in…

Details

Blindfolded training could help doctors save young lives

In a simulation training study, pediatric team leaders who wore a blindfold improved their leadership skills ratings by 11% over the course of 3 resuscitation scenarios, versus 5% for non-blindfolded leaders. Published in Frontiers in Pediatrics, the findings demonstrate a promising tool for improving training and outcomes in pediatric resuscitation. “Our study suggests that blindfolding…

Details

What’s age got to do with it?

Sophia Antipolis, 14 February 2019: It’s often said: It’s not how old you are, it’s how old you feel. New research shows that physiological age is a better predictor of survival than chronological age. The study is published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).…

Details